April 21, 2020 – Governor Andrew Cuomo said the charges brought by New York’s Department of Financial Services are the first against a major opioid manufacturer in the regulator’s probe into entities that contributed to the nationwide opioid crisis.
New York accused Mallinckrodt of overstating the benefits of long-term opioid treatment, downplaying the risks of addiction and abuse, and knowing its conduct would result in the payment of fraudulent insurance claims on unnecessary prescriptions.
Mallinckrodt is the largest maker of generic opioids in the United States. According to New York, it supplied more than 1 billion pills to about 5 million policyholders in the state from 2009 to 2019.
The company was charged with violating two New York insurance laws, with civil penalties of up to $5,000 per violation.
Tuesday’s charges follow Mallinckrodt’s Feb. 25 agreement to pay $1.6 billion to settle thousands of lawsuits by state and local governments over its role in the U.S. opioid epidemic.
“I don’t really do endorsements. I’m not shy about sharing my views, but I hate…
THE LOSS LINGERS – Oct. 24, 2024 - Perry's younger sister, Caitlin Morrison, 43, and his…
AUDIO – PROFITS BEFORE PEOPLE? – Oct. 25, 2025 - Big addiction treatment “campuses” aren’t…
VIDEO – MUSICAL INTERLUDE – 50,272,624 views - June 17, 2022 - As featured in…
VIDEO – JUNKIES LIVES MATTER – Oct. 25, 2024 - According to ChatGPT, Orange County,…
THE COMEBACK KID – Oct. 2024 - I celebrated my 70th birthday this year, on…